Correlation Between Theseus Pharmaceuticals and Kura Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Theseus Pharmaceuticals and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theseus Pharmaceuticals and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Theseus Pharmaceuticals and Kura Oncology, you can compare the effects of market volatilities on Theseus Pharmaceuticals and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theseus Pharmaceuticals with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theseus Pharmaceuticals and Kura Oncology.

Diversification Opportunities for Theseus Pharmaceuticals and Kura Oncology

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Theseus and Kura is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Theseus Pharmaceuticals and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Theseus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theseus Pharmaceuticals are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Theseus Pharmaceuticals i.e., Theseus Pharmaceuticals and Kura Oncology go up and down completely randomly.

Pair Corralation between Theseus Pharmaceuticals and Kura Oncology

If you would invest  371.00  in Theseus Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of  0.00  from holding Theseus Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy0.97%
ValuesDaily Returns

Theseus Pharmaceuticals  vs.  Kura Oncology

 Performance 
       Timeline  
Theseus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Theseus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Theseus Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Kura Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Theseus Pharmaceuticals and Kura Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Theseus Pharmaceuticals and Kura Oncology

The main advantage of trading using opposite Theseus Pharmaceuticals and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Theseus Pharmaceuticals position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.
The idea behind Theseus Pharmaceuticals and Kura Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world